BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 110372
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110372
Figure 2
Figure 2 Immuno-expression of E cadherin in oral squamous cell carcinoma. A: Immuno-expression of E-cadherin is reduced with cytoplasmic relocation in oral squamous cell carcinoma (OSCC) [immunohistochemistry (IHC), 4 ×]; B: Immuno-expression of E-cadherin is reduced with cytoplasmic relocation in OSCC (IHC, 10 ×); C: Immuno-expression of E-cadherin is reduced with cytoplasmic relocation in OSCC (IHC 40 ×).


Write to the Help Desk